Characterisation & Potential Applications of Human iPS Cell Derived Neural Progenitor Cells


In 2012, Shinya Yamanaka was awarded a Nobel Prize for demonstrating
that adult cells can be reprogrammed into induced pluripotent stem
cells (iPS cells) using defined factors- Oct3/4, KLF4, Sox2 and c-Myc1
in mouse in 2006 and human in 2007. iPS cells can be differentiated
into human neural progenitor cells (hNPCs) and cerebral cortical
neurons (hCCNs) from healthy donors and patients. Traditionally,
animal models have been utilised for disease research, however the
genetic and physiological differences between animal and humans means
these results are not always translatable to results in a human
system. By using iPS-derived human cells as an alternative system for
disease modelling and drug discovery, some of these issues can be
overcome. We characterised iPS cell-derived human neural progenitor
cells and their progeny produced using optimised methods to examine
their suitability to model neurobiology in a dish for use in numerous
applications including drug screening and toxicity testing.

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG,, Labhoo Ltd 2003-2021